65,437 trials
Breast Cancer
Primary: OA/US Specificity (Downgrade (%) for BI-RADS 4A & 4B) of Benign Masses — 41.1 percentage of masses
Sarcoma
Primary: Average Number of Months of Progression-free Survival — 4.1; 4.1 months
Healthy Adults
Primary: Plasma Ketone Concentrations — 69; 294; 109; 363 µmol/L
Pain
Primary: Pain Score (NRS 0-10) — 5.1; 4.2 units on a scale
Multiple Sclerosis · Encephalitis
Primary: Change in Cognition as Assessed by Change in Paced Auditory Serial Addition Test Scores — -1.20; -0.33 score on a scale
X-Linked Dystonia Parkinsonism
Primary: The Body Mass Index (BMI in kg/m^2) Using a Bathroom Weighing Scale. — 18.86; 18.17; 19.00; 18.31 Kg/m^2 — p=0.084
Solid Tumor
Primary: Summary of Derived Best Tumor Response Per the Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 - Dose Escalation (Efficacy Evaluable Population) — 0…
Partial-Onset or Primary Generalized Tonic-Clonic Seizures
Primary: Percentage of Participants With Treatment Emergent Adverse Events (AEs) and Treatment Emergent Serious Adverse Events (SAEs) for Total Group of Participants - Core Phase…
Congestive Heart Failure · Emotions · Patient Compliance
Primary: Feasibility of the PP-based Health Behavior Intervention — 8.7 sessions completed out of 12 sessions
Cystitis · Cystitis;Puerperium · Pyelonephritis
Primary: Number of Participants Who Have Cystitis — 4; 4 Participants
Metastatic Prostate Cancer
Primary: Immune Response to Sipuleucel-T — 29.6; 25.45 Spots per ml
Pleural Carcinomatosis
Primary: Pleural Carcinomatosis Identification (Compared to Standard Biopsies). Qualitative Criteria. — 8; 24; 21; 0 Participants — p=0.0003
Ischemia/Reperfusion Injury After Neonatal Cardiac Surgery · Inflammatory Reaction After Neonatal Cardiac Surgery
Primary: Change in Biochemical Markers of Ischemia/Reperfusion Injury and Oxidative Damage (Positive ~ Increase From Pre-op) — 0.46; 0.64; 11.52; 26.98 ng/ml — p=>0.05
Hypercholesterolemia
Primary: Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C) at Month 2 — 2.783; -27.478 percent change — p=<0.001
Hypercholesterolemia · Atherosclerosis · Statin Adverse Reaction
Primary: Percent Change From Baseline to Week 12 in Low-Density Lipoprotein Cholesterol (LDL-C) — 4.99; -23.46 percent change — p=<0.001